← Back to patent-cliff list
CAS 15258-72-7
1-chloro-2-(chloromethyl)-3-nitrobenzene
Codes: ANAG-001
Application context (from source-drug indications)
Essential thrombocythaemiaAnagrelide Hydrochloride HydrateMyeloproliferative neoplasmAnagrelide Hydrochloride Hydrate血小板增多Anagrelide Hydrochloride HydrateMyelofibrosisAnagrelide Hydrochloride HydrateChronic myeloid leukaemiaAnagrelide Hydrochloride HydratePolycythaemia veraAnagrelide Hydrochloride Hydrate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Anagrelide Hydrochloride Hydrate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1-chloro-2-(chloromethyl)-3-nitrobenzene→ethyl glycinate→ethyl 2-((2-chloro-6-nitrobenzyl)amino)acetate→ethyl 2-((2-amino-6-chlorobenzyl)amino)acetate→6-chloro-3,5-dihydroimidazo[2,1-b]quinazolin-2(1H)-one
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.